Glenn Greenberg's ELV Position Overview
Glenn Greenberg (via Brave Warrior Advisors, LLC) currently holds 1.8M shares of Elevance Health, Inc. (ELV) worth $592.6 M, representing 13.76% of the portfolio. First purchased in 2019-Q3, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Glenn Greenberg has maintained a strategic position in ELV, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 724.3K shares. Largest reduction occurred in Q2 2025, reducing 467.9K shares.
Analysis based on 13F filings available since 2013 Q2
Glenn Greenberg's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Glenn Greenberg
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2019 | +638,397 | New Buy | 638,397 | $240.10 |
| Q4 2019 | -10,745 | Reduce 1.68% | 627,652 | $302.03 |
| Q1 2020 | +247,815 | Add 39.48% | 875,467 | $227.04 |
| Q2 2020 | -103,999 | Reduce 11.88% | 771,468 | $262.98 |
| Q3 2020 | -7,541 | Reduce 0.98% | 763,927 | $268.59 |
| Q4 2020 | +7,208 | Add 0.94% | 771,135 | $321.09 |
| Q1 2021 | +392,594 | Add 50.91% | 1.16 M | $358.95 |
| Q2 2021 | -18,313 | Reduce 1.57% | 1.15 M | $381.80 |
| Q3 2021 | +225,846 | Add 19.72% | 1.37 M | $372.80 |
| Q4 2021 | -5,477 | Reduce 0.40% | 1.37 M | $463.54 |
| Q1 2022 | -12,536 | Reduce 0.92% | 1.35 M | $491.22 |
| Q2 2022 | -141,973 | Reduce 10.49% | 1.21 M | $482.58 |
| Q3 2022 | -21,405 | Reduce 1.77% | 1.19 M | $454.24 |
| Q4 2022 | -317,456 | Reduce 26.68% | 872,415 | $512.97 |
| Q1 2023 | +212,353 | Add 24.34% | 1.08 M | $459.81 |
| Q2 2023 | +236,504 | Add 21.80% | 1.32 M | $444.29 |
| Q3 2023 | +306,326 | Add 23.18% | 1.63 M | $435.42 |
| Q4 2023 | +129,055 | Add 7.93% | 1.76 M | $471.56 |
| Q1 2024 | -110,816 | Reduce 6.31% | 1.65 M | $518.54 |
| Q2 2024 | -12,710 | Reduce 0.77% | 1.63 M | $541.86 |
| Q3 2024 | +8,286 | Add 0.51% | 1.64 M | $520.00 |
| Q4 2024 | -11,436 | Reduce 0.70% | 1.63 M | $368.90 |
| Q1 2025 | -52,407 | Reduce 3.22% | 1.58 M | $434.96 |
| Q2 2025 | -467,917 | Reduce 29.66% | 1.11 M | $388.96 |
| Q3 2025 | +724,349 | Add 65.28% | 1.83 M | $323.12 |
Glenn Greenberg's Elevance Health Investment FAQs
Glenn Greenberg first purchased Elevance Health, Inc. (ELV) in Q3 2019, acquiring 638,397 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Glenn Greenberg has held Elevance Health, Inc. (ELV) for 25 quarters since Q3 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Glenn Greenberg's largest addition to Elevance Health, Inc. (ELV) was in Q3 2025, adding 1,834,002 shares worth $592.6 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Glenn Greenberg's firm, Brave Warrior Advisors, LLC, owns 1,834,002 shares of Elevance Health, Inc. (ELV), valued at approximately $592.6 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Elevance Health, Inc. (ELV) represents approximately 13.76% of Glenn Greenberg's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Glenn Greenberg's peak holding in Elevance Health, Inc. (ELV) was 1,834,002 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.